A new study reveals an involvement of SLC22A3 in the development of familial oesophageal squamous cell carcinoma (ESCC). Reduced expression of SLC22A3 is detected not only in ESCC tumours but also in non-tumour tissues of patients with familial ESCC. Interestingly, adenosine-to-inosine editing of SLC22A3 mRNA is proposed to drive early tumour invasion and metastasis, by inhibiting SLC22A3 expression.
This is a preview of subscription content, log in via an institution to check access.
References
Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87–108 (2015).
Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 17, 83–96 (2016).
Paz-Yaacov, N. et al. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep. 13, 267–276 (2015).
Koepsell, H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol. Sci. 25, 375–381 (2004).
Eeles, R. A. et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 40, 316–321 (2008).
Grisanzio, C. et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc. Natl Acad. Sci. USA 109, 11252–11257 (2012).
Fu, L. et al. RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer. Proc. Natl Acad. Sci. USA 114, E4631–E4640 (2017).
Wu, C. et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat. Genet. 43, 679–684 (2011).
Gumireddy, K. et al. The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nat. Commun. 7, 10715 (2016).
Acknowledgements
The author thanks J.M. Murray for critical reading of the manuscript. Research in the Nishikura lab is supported by grants from the NIH (R01GM040536 and R01CA175058), the Macula Vision Research Foundation and the Japan Society for the Promotion of Science (S13204). The author acknowledges services provided by Shared Facilities of The Wistar Cancer Center, which are supported by the National Cancer Institute (P30CA010815). The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Nishikura, K. RNA editing of SLC22A3 mRNAs: causative relevance to familial ESCC?. Nat Rev Gastroenterol Hepatol 14, 569–570 (2017). https://doi.org/10.1038/nrgastro.2017.102
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2017.102
- Springer Nature Limited
This article is cited by
-
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia
Clinical Epigenetics (2022)